Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Low-dose Sofosbuvir in Dialysis-dependent HCV Patients
NCT03883698Phase 3Completed
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Start
- Mar 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sofosbuvir in hepatitis C (HCV) (3 arms), sponsored by Sanjay Gandhi Postgraduate Institute of Medical Sciences. Primary endpoint: Pharmacokinetics of Sofosbuvir and GS-331007 at Day 7. Started Mar 2019; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03883698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03883698.